- Home
- PULM vs PYPD Comparison
PULM vs PYPD Comparison
Compare PULM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- PYPD
- Stock Information
- Founded
- PULM 2003
- PYPD 2008
- Country
- PULM United States
- PYPD Israel
- Employees
- PULM N/A
- PYPD N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- PYPD Medical/Dental Instruments
- Sector
- PULM Health Care
- PYPD Health Care
- Exchange
- PULM Nasdaq
- PYPD Nasdaq
- Market Cap
- PULM 30.9M
- PYPD 25.0M
- IPO Year
- PULM N/A
- PYPD 2020
- Fundamental
- Price
- PULM $6.31
- PYPD $2.74
- Analyst Decision
- PULM
- PYPD Strong Buy
- Analyst Count
- PULM 0
- PYPD 2
- Target Price
- PULM N/A
- PYPD $10.50
- AVG Volume (30 Days)
- PULM 19.7K
- PYPD 10.6K
- Earning Date
- PULM 05-09-2025
- PYPD 05-07-2025
- Dividend Yield
- PULM N/A
- PYPD N/A
- EPS Growth
- PULM N/A
- PYPD N/A
- EPS
- PULM N/A
- PYPD N/A
- Revenue
- PULM $7,806,000.00
- PYPD N/A
- Revenue This Year
- PULM N/A
- PYPD N/A
- Revenue Next Year
- PULM $134.88
- PYPD N/A
- P/E Ratio
- PULM N/A
- PYPD N/A
- Revenue Growth
- PULM 6.96
- PYPD N/A
- 52 Week Low
- PULM $1.72
- PYPD $2.30
- 52 Week High
- PULM $10.40
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- PULM 49.72
- PYPD 51.73
- Support Level
- PULM $5.31
- PYPD $2.33
- Resistance Level
- PULM $6.07
- PYPD $2.61
- Average True Range (ATR)
- PULM 0.50
- PYPD 0.11
- MACD
- PULM 0.03
- PYPD 0.03
- Stochastic Oscillator
- PULM 63.59
- PYPD 94.83
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.